Lamberto L. P.
- Country
- Spain
- Department
- #2408: Neurología
Research Overview
- Efficacy and Safety of Remibrutinib in Patients with Secondary Progressive Multiple Sclerosis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
- Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Trial of Intrathecal Mivelsiran (ALN‑961583) in Adults with Early‑Stage Down Syndrome‑Associated Alzheimer’s Disease
- Long-term Evaluation of Safety, Tolerability, and Efficacy of AL002 and Florquinitau (18F) in Patients with Alzheimer's Disease
Data & Insights
Has run more than one trial at 185 of 382 partner sites.
Specializations
Neurodegenerative Disease and Cognitive Disorders
Clinical research activity includes Alzheimer’s disease, mild cognitive impairment, dementia, early Parkinson’s disease, and broader neurocognitive disorders, with attention to symptomatic decline and disease-modifying strategies.
- Alzheimer’s disease
- Mild cognitive impairment
- Dementia
- Parkinson’s disease
- Neurocognitive disorders
Work in this area also extends to tauopathies, neurodegenerative diseases, and biomarker-informed approaches in cognitive impairment.
Autoimmune and Inflammatory Diseases
The investigator is involved in trials across systemic lupus erythematosus, cutaneous lupus erythematosus, systemic sclerosis, Sjögren’s syndrome, and bullous pemphigoid, reflecting a strong focus on immune-mediated disease control.
- Systemic lupus erythematosus
- Systemic sclerosis
- Sjögren’s syndrome
- Bullous pemphigoid
- Cutaneous lupus erythematosus
Additional interests include autoimmune diseases, immune system diseases, interstitial lung disease associated with systemic autoimmunity, and uveitis.
Kidney Disease and Transplantation
Research involvement covers chronic kidney disease, IgA nephropathy, lupus nephritis, focal segmental glomerulosclerosis, and end-stage kidney disease, alongside transplant-related renal complications.
- Chronic kidney disease
- IgA nephropathy
- Lupus nephritis
- End-stage kidney disease
- Kidney transplantation
This portfolio also includes delayed graft function, proteinuria, renal inflammation, and dialysis-associated complications.
Hematologic Malignancies and Plasma Cell Disorders
Clinical trial activity spans multiple myeloma, smoldering myeloma, follicular lymphoma, marginal zone lymphoma, diffuse large B-cell lymphoma, and myelofibrosis.
- Multiple myeloma
- Smoldering myeloma
- Follicular lymphoma
- Diffuse large B-cell lymphoma
- Myelofibrosis
Other areas include essential thrombocythemia, chronic myeloid leukemia, and relapsed or refractory B-cell malignancies.
Respiratory, Cardiovascular, and Metabolic Conditions
The investigator also participates in studies of asthma, chronic obstructive pulmonary disease, interstitial lung disease, acute pulmonary embolism, and community-acquired pneumonia, as well as cardiometabolic disease.
- Asthma
- Chronic obstructive pulmonary disease
- Interstitial lung disease
- Acute pulmonary embolism
- Obesity
Related interests include atherosclerotic cardiovascular disease, heart failure, acute respiratory infection, and metabolic risk reduction.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.